Other languages BioAdaptives, Inc.

Equities

BDPT

US09072U1079

Market Closed - OTC Markets Other stock markets 03:37:56 2024-05-01 pm EDT			5-day change	1st Jan Change
0.0005 ^USD	-16.67%		+25.00%	0.00%

Apr. 10	BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 22	Bioadaptives, Inc. Announces Naturacomplete?, an All-In-One Supplement to Optimize Its Ai-Based FYO Obesity Management System	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 10
Bioadaptives, Inc. Announces Naturacomplete?, an All-In-One Supplement to Optimize Its Ai-Based FYO Obesity Management System	Feb. 22
BioAdaptives Announces Signing of a New Distributor?s Agreement for AI Body Composition Measuring App and New Weight Management System	Jan. 17
BioAdaptives Inc. Announces the Development of PROTEINnMORETM	Dec. 14
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula	Nov. 16
BioAdaptives, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
BioAdaptives, Inc. Highlights Continued Success of Popular LUNG ARMOR System as US Enters Flu Season	Nov. 09
BioAdaptives, Inc. Announces Nationwide Launch of Lung Fortress Natural Supplement	23-10-10
BioAdaptives, Inc. Commences Development of A New Supplement for Women?S Health	23-10-05
BioAdaptives, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11
BioAdaptives, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12
BioAdaptives, Inc. Announces the Appointment of David Allen to its Board of Directors	23-04-13
BioAdaptives, Inc. Signs Non-Exclusive Marketing Agreement with World Wellness, LLC	23-04-06
BioAdaptives, Inc. Announces the Appointment of Dr. Yaguang Liu to its Board of Directors	23-04-05
BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31
BioAdaptives, Inc. Auditor Raises 'Going Concern' Doubt	23-03-30
BioAdaptives Signs Non-Exclusive License with LY Research to Market Patented Product for Glucose Management	23-03-28
BioAdaptives, Inc. Establishes A Wholesale Division to Expand Marketing Presence in USD 151.9 Billion Global Dietary Supplement Market	22-12-08
BioAdaptives, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
BioAdaptives, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages BioAdaptives, Inc.

Equities

BDPT

US09072U1079

Other languages

Filters